COVID-19 related thrombosis: A mini-review

CONCLUSIONS: Contemporary rapidly evolving evidence shows that COVID-19 associated thrombosis was a novel clinical entity, especially in severely ill COVID-19 patients. There are multiple society-driven guidelines only, but without any level 1 evidence for management regimen. The ideal dose for prophylaxis is not established and may vary depending on balance of bleeding and thrombosis risk. The risk of bleeding may be increased in patients in intensive care unit.PMID:35403487 | PMC:PMC9006089 | DOI:10.1177/02683555211052170
Source: Phlebology - Category: Internal Medicine Authors: Source Type: research